Phase I study of extracts from Lentinula edodes mycelia in advanced cancer patients

Phase I study of extracts from Lentinula edodes mycelia in advanced cancer patients - Phase I study of extracts from Lentinula edodes mycelia in advanced cancer patients

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000002773

Enrollment

Registered

2009-11-17

Start date

2009-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

advanced cancer

Interventions

extracts from Lentinula edodes mycelia

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patient with advanced cancer No severe organ function impairment Performance Status 0-1 Patient who is able to take oral medications written informed consent of the patient

Exclusion criteria

Exclusion criteria: Pregnant female Patient allergic to shiitake mushroom Patient with ileus

Design outcomes

Primary

Measure	Time frame
Safety	—

Secondary

Measure	Time frame
immunoactivity quality of life	—

Countries

Japan

Contacts

Public ContactSatoshi Ohno

Tokyo Women's Medical University IREIIMS

ohno@imcir.twmu.ac.jp03-3353-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026